{"id":760110,"date":"2025-08-28T17:13:01","date_gmt":"2025-08-28T17:13:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=760110"},"modified":"2025-08-28T17:13:01","modified_gmt":"2025-08-28T17:13:01","slug":"announce-strategic-partnership-to-enhance-access-to-highquality-antibodies","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/announce-strategic-partnership-to-enhance-access-to-highquality-antibodies_760110.html","title":{"rendered":"Announce Strategic Partnership to Enhance Access to High-Quality Antibodies"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Cambridge &#8211; August 28th 2025 &#8211;&nbsp;<\/strong>Antibodies.com, a trusted provider of high-quality antibodies and research reagents, is proud to announce a strategic partnership with Carl Roth, a leading supplier of laboratory and research chemicals. This collaboration represents an important milestone, expanding access to Antibodies.com&rsquo;s cutting-edge portfolio for Carl Roth&rsquo;s customers across Europe.<\/p>\n<p style=\"text-align: justify;\">Through this partnership, Carl Roth will distribute Antibodies.com&rsquo;s extensive collection of antibodies and immunoassays &#8211; including monoclonal, polyclonal, and recombinant products &#8211; designed to meet the needs of researchers in academia, biotechnology, and the pharmaceutical industry. With a strong reputation for quality, reliability, and affordability, Antibodies.com complements Carl Roth&rsquo;s mission to deliver best-in-class solutions for scientific discovery.<\/p>\n<p style=\"text-align: justify;\"><em>&#8220;We are excited to partner with Carl Roth, a company that shares our dedication to advancing scientific research,&#8221;<\/em> said Sebastian Newlove, Co-Founder of Antibodies.com. <em>&#8220;Together, we aim to make high-quality antibodies more accessible, enabling researchers to achieve their goals with confidence and efficiency.&#8221;<\/em><\/p>\n<p style=\"text-align: justify;\">Dr. Leonie Hacker, Head of Product Management Chemistry &amp; Life Science at Carl Roth, added: <em>&#8220;This partnership represents a significant step forward in our commitment to empowering researchers with the best tools available. By integrating Antibodies.com&rsquo;s high-quality antibodies into our offerings, we are ensuring that our customers have access to innovative products at fair prices, supporting their groundbreaking work in life sciences.&#8221;<\/em><\/p>\n<p style=\"text-align: justify;\">Antibodies.com&rsquo;s customer-focused approach &#8211; emphasising transparency, rigorous quality control, and exceptional value &#8211; combined with Carl Roth&rsquo;s established distribution network, will streamline access to these products, ensuring seamless delivery and support for researchers across Europe.<\/p>\n<p style=\"text-align: justify;\">This collaboration underscores the shared vision of both companies: to foster innovation and excellence within the scientific community. Researchers can now explore Antibodies.com&rsquo;s antibody portfolio through Carl Roth&rsquo;s online platform or by contacting their sales representatives for tailored support.<\/p>\n<p style=\"text-align: justify;\">For more information about this partnership or to browse the expanded product offerings, visit <a rel=\"nofollow\" href=\"http:\/\/www.antibodies.com\/?utm_source=chatgpt.com\" target=\"_new\">www.antibodies.com<\/a> or <a rel=\"nofollow\" href=\"http:\/\/www.carlroth.com\/?utm_source=chatgpt.com\" target=\"_new\">www.carlroth.com<\/a>.<\/p>\n<p style=\"text-align: justify;\"><strong>About Carl Roth<\/strong><\/p>\n<p style=\"text-align: justify;\">Carl Roth, headquartered in Karlsruhe, Germany, is a leading distributor of laboratory supplies, chemicals, and equipment. With a legacy of excellence spanning decades, Carl Roth serves researchers and professionals in life sciences, chemistry, and beyond, delivering high-quality products and exceptional customer service.<\/p>\n<p style=\"text-align: justify;\"><strong>About Antibodies.com<\/strong><\/p>\n<p style=\"text-align: justify;\">Antibodies.com is a global provider of high-quality antibodies and research reagents, dedicated to supporting scientific discovery. With a focus on affordability, reliability, and innovation, Antibodies.com empowers researchers with the tools they need to advance their work in immunology, oncology, and other critical fields.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/Antibodies.com_165401.html\" rel=\"nofollow\">antibodies.com<\/a><br \/><strong>Contact Person:<\/strong> Christian Lautenschlager<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=announce-strategic-partnership-to-enhance-access-to-highquality-antibodies\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> + 44 (0)1223 298 875<br \/><strong>Country:<\/strong> United Kingdom<br \/><strong>Website:<\/strong> <a href=\"http:\/\/Antibodies.com\" target=\"_blank\" rel=\"nofollow\">Antibodies.com<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=announce-strategic-partnership-to-enhance-access-to-highquality-antibodies\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cambridge &#8211; August 28th 2025 &#8211;&nbsp;Antibodies.com, a trusted provider of high-quality antibodies and research reagents, is proud to announce a strategic partnership with Carl Roth, a leading supplier of laboratory and research chemicals. This collaboration represents an important milestone, expanding &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/announce-strategic-partnership-to-enhance-access-to-highquality-antibodies_760110.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[447,410,406,423,403],"tags":[],"class_list":["post-760110","post","type-post","status-publish","format-standard","hentry","category-Education","category-Manufacturing-Industry","category-Pharmaceuticals-Biotech","category-Professional-Services","category-UK"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/760110","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=760110"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/760110\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=760110"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=760110"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=760110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}